A leading global contract research organization, BioAgilytix delivers next-level science to established and emerging pharmaceutical and biotechnology partners in all phases of drug development. We provide PK, immunogenicity, biomarkers, and cell-based assay services supporting therapeutic development and release testing across disease states from laboratories in Durham, North Carolina; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany. Our experienced scientists relish complex bioanalytical projects and deliver a collaborative, high-science experience that enables therapeutic innovations to reach patients faster.